PKPHD   $7.0  -28.57% Market Closed


Current temperature:
ST: None, Cor:

ISIN US70469W2052
ceo Mr. Neil T. Reithinger CPA
Peak Pharmaceuticals, Inc. does not have significant operations. Previously, it was operated as a bio­pharmaceutical and nutraceutical company, as well as focuses to develop, manufacture, market, and sell medicinal products based on extracts from hemp. The company was formerly known as Cannabis Therapy Corporation and changed its name to Peak Pharmaceuticals, Inc. in December 2014. Peak Pharmaceuticals, Inc. was incorporated in 2007 and is based in Scottsdale, Arizona.